. Company and subsidiaries (Based on the consolidated financial statements of the Company as of September 30, 2018) 4. Details of disposed assets (New ordinary shares to be waived) 4.1 Type of assets disposed
-patients department inclined by 24.6% and 8.9% respectively. Causing the increasing in the total revenue from Gastrointestinal diseases and seasonal diceases such as Nasopharyngitis, Influenza, Dengue Fever
-patients department inclined by 23.3 % and 7.6 % respectively. Causing from Gastrointestinal diseases and Dengue Fever including non-communicable diseases such as cardiovascular disease, neurologic diseases
were stemmed from both Wattanapat Hospital Trang Public Company Limited and its subsidiary. The revenue from Out-patients department was inclined by 20.1%, on the contrary, In-patients department was
and Out-patients department inclined by 6.6% and 6.5% respectively. Causing from Gastrointestinal diseases and Dengue Fever including non-communicable diseases such cardiovascular disease, neurologic
-patients and Out-patients department inclined by 31.5 % and 5.9 % respectively. Causing from Gastrointestinal diseases and Dengue Fever including non-communicable diseases such as cardiovascular disease
(CSR) gains a more significant role as investors and foreign companies give more weight to the CSR factor when making investment decisions and thus are more inclined to invest in a company or do business
declined by 4.6%, on the contrary, Out-patients department inclined by 7.3%. The proporation of In-patients in the Q1/2018 and Q1/2019 were 69% and 67% respectively, decreasing by 2%. The number of both in
in RAM: 1.06% 3. Dr. Rukkagee Kanjanapitak is the daughter of Mr. Aurchat Kanjanapitak who is a director of RAM. Shareholding in the Company (none) Shareholding in RAM 1.76% 5. Details of disposed